03:58 PM EDT, 09/26/2024 (MT Newswires) -- Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index shedding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.

The iShares Biotechnology ETF (IBB) rose 1%.

In corporate news, Pasithea Therapeutics ( KTTA ) shares surged 46% after the firm said interim data from a phase 1 trial showed that its experimental drug PAS-004 was effective and safe in treating neurofibromatosis type 1 and other cancer indications.

Telesis Bio ( TBIO ) shares soared 58% after it reported a partnership with Beckman Coulter Life Sciences late Wednesday to set up scalable bio-foundries to deliver on-premise DNA synthesis.

Biomea Fusion ( BMEA ) shares rose 5% after the US Food and Drug Administration lifted a clinical hold on its phase 1/2 trials evaluating BMF-219 in type 1 and type 2 diabetes treatment.

Guardian Pharmacy Services ( GRDN ) shares debuted on Nasdaq, with the stock last up about 15% compared with its initial public offering price of $14 per share.